Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06906302 · ClinicalTrials.gov registry record · NA
RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV
A NA study of Intimate Partner Violence (IPV), sponsored by Boston University.
- Recruiting
- Registry status
- NA
- Development phase
- 172
- Enrollment target
- 3
- Study locations
NCT06906302: Recruiting NA study of Intimate Partner Violence (IPV), sponsored by Boston University.
NCT06906302 is a NA study of Intimate Partner Violence (IPV) that is actively recruiting participants, run by Boston University. The registered enrollment target is 172 participants, below the 568-participant average among 5 other Intimate Partner Violence (IPV) trials with a reported enrollment target (70% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06906302, a NA study of Intimate Partner Violence (IPV), is actively recruiting participants, sponsored by Boston University.
- RECRUITING
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced IPV in the past 12 months: Recovering from IPV through Strength and Empowerment (RISE) and advocacy-based Enhanced Care as Usual (ECAU). The RISE intervention includes up to 8 sessions and includes specific topic areas (e.g., social support, health effects, resources). The other intervention, ECAU, includes a single session that includes supportive education about IPV and health effects, discussion of ways to increase safety, and information about resources. This study will test which approach is better for improving self-efficacy and other aspects of health. Participants will answer surveys about their self-efficacy and other health and safety indicators (e.g., mental health symptoms) right before receiving treatment, approximately 12 weeks later, and then every three months after that for one year. Participation in this research will last about 15 months.
Primary Outcome
Self-efficacy will be assessed with the General Self-Efficacy Scale (GSES), a 10-item instrument with possible responses for each item from 1 to 4 where 1= Not at all true, 2= Hardly true, 3= Moderately true, and 4=Exactly true.Scores can range from 10 to 40 and higher scores indicate more self efficacy.
Conditions Studied
Interventions
- BEHAVIORAL RISE
- BEHAVIORAL Advocacy-based ECAU
Study Locations (3)
Massachusetts
- VA Boston Healthcare System - Boston
Minnesota
- VA Minneapolis Healthcare System - Minneapolis
Pennsylvania
- VA Philadelphia Healthcare System - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2025-09-15 |
| Est. Completion | 2030-01 |
| Phase | NA |
What NCT06906302 shows while recruiting
NCT06906302 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, below the 568-participant average among 5 other Intimate Partner Violence (IPV) trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Intimate Partner Violence (IPV) appearing as the primary indexed condition, and to 2 interventions - of which RISE is the first listed.
NCT06906302 reports a single indexed study location in Massachusetts, Minnesota, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06906302 about?
NCT06906302 is a clinical study titled "RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV". This study aims to improve treatment for Veterans Health Administration (VHA) patients who experience intimate partner violence (IPV). This study will evaluate two brief counseling interventions for VHA patients who have experienced IPV in the past 12 months: Recovering from IPV through Strength and...
What is the current status of trial NCT06906302?
This trial is currently recruiting. It is a NA study. The enrollment target is 172 participants. The study started on 2025-09-15. Estimated completion is 2030-01.
What conditions does trial NCT06906302 study?
This clinical trial studies the following conditions: Intimate Partner Violence (IPV).
What interventions are being tested in trial NCT06906302?
The interventions under investigation include: RISE (BEHAVIORAL), Advocacy-based ECAU (BEHAVIORAL).
Who is sponsoring clinical trial NCT06906302?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06906302 being conducted?
This trial has 3 study locations across Massachusetts, Minnesota, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intimate Partner Violence (IPV)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alcohol and Sexual Communication Among Couples in the Laboratory
RECRUITING · NA
-
A Multi-Level Trauma-Informed Approach to Increase HIV Pre-exposure Prophylaxis Initiation Among Black Women
RECRUITING · NA
-
SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families
RECRUITING · NA
-
Get Better Together: Relationship Education For Military Couples
RECRUITING · NA
-
Addressing Reproductive Coercion in HEalth Settings - Kenya
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI